FDA OKs Farxiga for HFrEF

]]>(MedPage Today) -- Heart failure with reduced ejection fraction (HFrEF) can now be treated with the SGLT2 inhibitor dapagliflozin (Farxiga), the FDA announced."This approval provides patients with HFrEF an additional treatment option that can...